Cambient Family Office’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.72M Buy
8,340
+59
+0.7% +$27.7K 0.46% 53
2026
Q1
$3.28M Buy
8,281
+1,269
+18% +$574K 0.46% 55
2025
Q4
$3.29M Buy
+7,012
New +$3.11M 0.47% 54

Other funds holding SNPS

Cambient Family Office's SNPS Position: Q2 2026 in Review

Cambient Family Office increased its Synopsys (SNPS) stake by 0.71% in Q2 2026, buying an estimated $27.7K and bringing the position to 8,340 shares worth $3.72M. The position accounts for 0.46% of the portfolio, ranked #53.

Cambient Family Office first reported a position in SNPS in Q4 2025 and has held it in 3 quarters since. 1,443 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Cambient Family Office held 8,340 shares of Synopsys worth $3.72M as of Q2 2026.
  • Cambient Family Office bought 59 Synopsys shares in Q2 2026, an estimated $27.7K.
  • Synopsys made up 0.46% of Cambient Family Office's portfolio in Q2 2026, its #53 holding.
  • Cambient Family Office first reported a position in Synopsys in Q4 2025 and has held it in 3 quarters since.
  • 1,443 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.